Effects of partial silencing of genes coding for enzymes involved in glycolysis and tricarboxylic acid cycle on the enterance of human fibroblasts to the S phase
- Aleksandra Konieczna†1,
- Aneta Szczepańska†1,
- Karolina Sawiuk1,
- Grzegorz Węgrzyn1 and
- Robert Łyżeń1Email author
© Konieczna et al.; licensee BioMed Central. 2015
Received: 29 January 2015
Accepted: 15 May 2015
Published: 28 May 2015
Previously published reports indicated that some enzymes of the central carbon metabolism (CCM), particularly those involved in glycolysis and the tricarboxylic acid cycle, may contribute to regulation of DNA replication. However, vast majority of such works was performed with the use of cancer cells, in the light of carcinogenesis. On the other hand, recent experiments conducted on bacterial models provided evidence for the direct genetic link between CCM and DNA replication. Therefore, we asked if silencing of genes coding for glycolytic and/or Krebs cycle enzymes may affect the control of DNA replication in normal human fibroblasts.
Particular genes coding for these enzymes were partially silenced with specific siRNAs. Such cells remained viable. We found that silencing of certain genes resulted in either less efficient or delayed enterance to the S phase. This concerned following genes: HK2, PFKM, TPI, GAPDH, ENO1, LDHA, CS1, ACO2, SUCLG2, SDHA, FH and MDH2. Decreased levels of expression of HK2, GADPH, CS1, ACO2, FH and MDH2 caused also a substantial impairment in DNA synthesis efficiency.
The presented results illustrate the complexity of the influence of genes coding for enzymes of glycolysis and the tricarboxylic acid cycle on the control of DNA replication in human fibroblasts, and indicate which of them are especially important in this process.
DNA replication is an essential processes in every cellular organism. Its precise regulation is crucial for adequate inheritance of the genetic material by daughter cells, and thus, proper functions of cells and organisms. The general scheme of DNA replication is common in prokaryotic and eukaryotic cells, however, these processes differ significantly in details. Nevertheless, it was indicated that principles of some regulatory mechanisms may be common, or at least similar, in both types of cells (for reviews see [1–3]).
Apart from involvement of specific proteins dedicated solely to control DNA replication, it appeared that enzymes which primary functions were ascribed to other processes can also play important roles in the regulation of genome duplication. Particularly, a new light on this problem was shed by recent studies on bacterial models. It was demonstrated that a direct link exists between central carbon metabolism and DNA replication regulation. Namely, effects of mutations in genes coding for Bacillus subtilis primase, helicase or lagging strand DNA polymerase could be specifically suppressed by mutations in genes encoding enzymes catalyzing terminal reactions of glycolysis (pgk, pgm, eno, pykA) . In Escherichia coli, effects of mutations in genes coding for the α subunit of DNA polymerase III, DNA polymerase III β clamp, and the primase were suppressed by deletions of genes coding for enzymes involved in glycolytic, acetate overflow and pentose-phosphate pathways . Moreover, temperature-sensitive phenotype of a mutation in the dnaA gene, coding for the replication initiator protein, was overcome by deletions of pta and ackA genes, coding for enzymes comprising the acetate overflow mechanism .
Although the studies mentioned above were conducted on bacterial models, recent analyse of previously published reports suggested that somewhat similar phenomenon might occur in eukaryotes. Additional roles of enzymes catalyzing reactions of glycolysis and tricaboxylic acid cycle were reported previously, and some of them include regulation of transcription, DNA binding and involvement in carcinogenesis (summarized and discussed in [7, 8]). Therefore, one might speculate that the direct link between central carbon metabolism and DNA replication is not restricted to bacterial cells, but could operate also in eukaryotes, including humans. On the other hand vast majority of such studies on human cells were performed with the use of cancer cell lines. Beside many advantages of the use of such lines, there are also drawbacks when considering regulatory mechanisms of DNA replication, as cancer cells have serious disturbances in the control of this process. Moreover, most studies concentrated on single enzymes, thus, different kinds of experiments were performed for particular genes and proteins. Therefore, the aim of this work was to assess the effects of silencing of genes coding for enzymes involved in all steps of glycolysis and tricarboxylic acid cycle on DNA replication in human non-cancer cells. As a model, we have chosen a human dermal fibroblast cell line, as a representative of cells that actively divide throughout the human life, while being non-transformed.
Silencing of genes coding for enzymes involved in glycolysis and tricarboxylic acid cycle
Human dermal fibroblasts, line HDFa, were used in all experiments. To silence the expression of genes encoding enzymes involved in glycolysis and tricarboxylic acid cycle, specific siRNAs were employed. Following genes were subjected to silencing: HK2 (coding for hexokinase 2), GPI (coding for phosphoglucose isomerase), PFKM (coding for phosphofructokinase M), ALDOA (coding for diphosphate aldolase A), TPI1 (coding for triosephosphate isomerase), GAPDH (coding for glyceraldehyde 3-phosphate dehydrogenase), PGK1 (coding for 3-phosphoglycerate kinase 1), PGAM1 (coding for phosphoglycerate mutase 1), ENO1 (coding for α-enolase), PKM (coding for pyruvate kinase M), LDHA (coding for lactate dehydrogenase A), CS1 (coding for citrate synthase 1), ACO2 (coding for aconitase 2), IDH2 (coding for isocitrate dehydrogenase 2), IDH3B (coding for isocitrate dehydrogenase 3B), OGDH (coding for α-ketoglutarate dehydrogenase), SUCLG2 (coding for GDP-forming succinyl-CoA synthetase 2), SDHA (succinate dehrydrogenase complex, subunit A), FH (coding for fumarase) and MDH2 (coding for malate dehydrogenase 2).
Enterance to the S phase following gene silencing
DNA synthesis in cells with silenced genes
These results may suggest that central carbon metabolism has a significant direct influence on the regulation of DNA replication through particular enzymes. At this stage of our knowledge it is impossible to deduce a specific mechanism by which these enzymes may link the metabolism to DNA synthesis. However, there are some insights from previous works, summarized below, which might shed some light on this phenomenon.
Impaired expression of HK2, coding for hexokinase 2, in cancer-associated fibroblasts (CAF) resulted in a G1 phase cell cycle arrest . Moreover, decreasing of HK2 expression in laryngeal squamous cell carcinoma (LSCC) reduced proliferation and cell viability by increasing G0-G1 ratio and apoptosis . Our results, indicating a decreased efficiency of the enterance to S phase after silencing of HK2, are compatible with those observations. One of isoenzymes of phosphofructokinase, was reported as a metabolic effector involved in the connection between glycolysis, cell proliferation and transformation . In fact, we also observed an impairment in DNA synthesis when PFKM expression was down-regulated. Moreover, depletion of GAPDH with RNA interference in human lung carcinoma A549 and UO31 cells stopped cell proliferation, and induced cell cycle arrest in G1 phase , which is in accordance to severe inhibition of the enterance into S phase reported here. Enolase could bind to specific DNA sequences and was found in nuclei of various cell types ,. Silencing of the ENO1 gene by siRNA inhibited the proliferation of the HCC cell line, which was accompanied by a shortened S phase and elongated G2/M phase of the cell cycle . Downregulation of ENO1 by siRNA inhibited cell migration and invasion in glioma cells. Reduction of ENO1 activity significantly decreased the phosphorylation of PI3K and Akt and reduced level of E-Cadherin, Cyclin D1, and p-Rb . Thus, it is intriguing that we have observed a delay in the enterance to S phase in cells with the partially silenced ENO1 gene. Lactate dehydrogenase was found in nuclei of mammalian cells, and its possible function in DNA replication was suggested ,. Knocking down the expression of LDHA in human hepatocellular carcinoma cells and pancreatic cancer cells inhibited cell growth dramatically by activation of the apoptosis pathway , ,. In human fibroblasts with the silenced LDHA gene, we have observed a decreased number of cells entering the S phase. In cancer cell lines, HeLa and SiHa, a decrease in expression of the CS1 gene was proportional to the malignancy, but this effect appeared to be linked to disturbed p53 function . On the other hand CS knockdown in human ovarian adenocarcinoma cell line SKOV3 and A2780 cells resulted in dysregulation of cell metabolism and downregulation of proliferation by decreasing phosphorylation of the extracellular signal-regulated kinase (ERK), a key component in the control of cell growth, and increasing of CASP7 encoded Caspase 7 involved in the caspase activation cascade responsible for the execution of apoptosis . In accordance to those reports, some negative effects on DNA replication in human fibroblasts with impaired expression of CS1 were found in this work. Silencing of expression of the SDHA gene resulted in a decrease of growth rate of cancer cells . In our experiments, such silencing caused less efficient enterance into S phase. Finally, fumarase has been proposed to act as a tumor suppressor . Knockdown of FH and SDHA/B genes in HeLA cells led to accumulation of fumarate and succinate, which act as competitive inhibitors of multiple α-ketoglutarate-dependent dioxygenases, including histone and DNA demethylases . Inactivation of histone demethylases, promotes G1 cell-cycle arrest, and induces genes for differentiation by selectively modulating the methylation states of histone H3 at lysines 4 (H3K4) and 9 (H3K9) . In human fibroblasts, we have observed a severe inhibition of the cell cycle at the stage of the S phase enterance under conditions of partial FH silencing.
The advantage of this study, in relation to previous works, discussed above in comparison to our work, is that the results presented here were obtained in the same cell line of human dermal fibroblasts. Generally, we have observed two types of the effects of silencing of particular genes: less efficient or delayed enterance to the S phase. Furthermore, reduction in efficiency in DNA synthesis was demonstrated in cells deficient in expression of the same genes as in the case of the less efficient enterance to the S phase. Therefore, the studies reported here provide a complex picture of the effects of a decreased levels of expression of the central carbon metabolism genes on DNA replication in human fibroblasts.
In the light of the general mechanisms of glycolysis, our results indicating different effects caused by silencing of GPI or GAPDH gene, an increase or severe decrease in efficiency of enterance into S phase, respectively, may be considered as intriguing. Glycolysis is a multi-step process, and each of the steps is performed either by one or multiple enzymes (isoforms). In contrast to the other steps, the second and sixth steps are catalyzed by the only one enzyme, GPI and GAPDH, respectively. GPI is the only enzyme catalyzing the second step of glycolysis, performing the conversion of glucose-6-phosphate to fructose-6-phosphate. Similarly, GAPDH is another bottleneck, the only enzyme catalyzing the sixth glycolytic step (except GAPDHS, a testis-specific isoform of GAPDH). Thus, metabolic effects (glycolysis down-regulation) of silencing GPI and GAPDH genes might be expected to be similar. Contrary to such presumption, the observed effects on cell proliferation have been completely different when either GPI or GAPDH were silenced with siRNA, as indicated above. The dramatic decrease in the fraction of cells entering to the S phase, as well as in viable cells count, when expression of GAPDH is impaired, indicates that GAPDH plays not only metabolic roles but also may be directly involved in the regulation of cell proliferation. In fact, despite the lack of direct proofs of GAPDH involvement in DNA replication and cell proliferation, this enzyme is considered as a potential cancer therapeutic target .
Although we are not able to propose specific mechanism(s) by which enzymes of glycolysis and tricarboxylic acid cycle can influence the regulation of DNA replication, it appears that the link between these metabolic pathways and the control of cell cycle, particularly DNA synthesis, is important. Plausibly, this link is direct through certain enzymes. Alternatively, metabolites which accumulate due to impairment of enzymatic activities might acts as signals in the regulatory processes as it was shown for fumarate and succinate . Irrespective of the detailed molecular mechanisms, it seems that DNA replication in human cells can be specifically regulated in response to the metabolic status of the cell, and there are several steps in glycolysis and tricarboxylic acid cycle which efficiency could be sensed by the DNA replication machinery. Finally, it is interesting that the direct links between central carbon metabolism and DNA replication appear to exist in both eukaryotic and prokaryotic systems (for discussions see [1, 7, 9]). Therefore, one might speculate that sensing the metabolic status of the cell by the cellular replication factory is an evolutionarily old phenomenon, which can be of particular importance for cell physiology.
Partial silencing of genes coding for enzymes catalyzing particular reactions of glycolysis and the tricarboxylic acid cycle illustrated the complexity of the influence of central carbon metabolism on the control of DNA replication in human fibroblasts. Following genes appear to be especially important in this process: HK2, PFKM, TPI, GAPDH, ENO1, LDHA, CS1, ACO2, SUCLG2, SDHA, FH and MDH2. These results, together with previously published reports describing the link between central carbon metabolism and DNA replication in bacteria, might suggest that sensing the metabolic status of the cell by the cellular replication factory is an evolutionarily old phenomenon, which can be of particular importance for cell physiology.
The Human Dermal Fibroblasts, adult HDFa (Cascade Biologics) were cultured in a 5 % CO2 humidified atmosphere at 37 °C in Dulbecco’s Modified Eagle’s Medium (DMEM; GIBCO) supplemented with 10 % fetal bovine serum (FBS; GIBCO).
Cell cycle synchronization
HDFa were subjected to gradual serum deprivation: 5 % FBS for 6 h, 1 % FBS for 6 h and DMEM without FBS for 12 h. The DNA content was analyzed by MuseTM Cell Analyzer. DNA histogram revealed that over 90 % of HDFa were inhibited at G0/G1 phase after starvation. Then, the cells were released into cell cycle by addition of 10 % serum.
Silencer® Select siRNAs (Small interfering RNAs) were purchased from Life Technology/Ambion. Transfections were performed with HiPerFect Transfection Reagent (Qiagen) as specified by the manufacturer. All targeted enzymes showed maximal knockdown 72 h after transfection.
Primers used for real-time qPCR to estimate mRNA levels of particular genes
F: 5’- CGAGGTCTGAGCAAGGAGAC
R: 5’- GTCCGGGGTAGCACACAC
F: 5’- GCTTTGCTGCGTACTTCCA
R: 5’- GTCCACACGGGTTCCAGA
F: 5’- GCCATCAGCCTTTGACAGA
R: 5’- CTCCAAAAGTGCCATCACTG
F: 5’- TCCTCTAGCCCGTGGAATC
R: 5’- AAGACGATGGCAGGGATG
F: 5’- GCTCAGAGCACCCGTATCAT
R: 5’- CACAAGGAAGCCATCCACAT
F: 5’- ACGGGAAGCTTGTCATCAAT
R: 5’- CATCGCCCCACTTGATTTT
F: 5’- CTCATGGATGAGGTGGTGAA
R: 5’- CACAGCAAGTGGCAGTGTCT
F: 5’- AGGCGCTCCTATGATGTCC
R: 5’- CGATCCTTACTGATGTTGCTGT
F: 5’- CAACCAGCTCCTCAGAATTGA
R: 5’- GCCAAGGGGTTTCTGAAGTT
F: 5’- ACCCTCCACTCAGCTGTCC
R: 5’- CCTGGAGGTGCTGCAGTAGT
F: 5’- GGTGGATGTTTACCGTGTGTT
R: 5’- TGGATCCCAGGATGTGACTC
F: 5’- TCCGACCCTTACCTGTCCTT
R: 5’- ACTTCCTGATTTGCCAGTCC
F: 5’- AGATTGTGTATGGACACCTGGA
R: 5’- TACGACTTGCCTCGCTCAAT
F: 5’- CCATCATCTGCAAAAACATCC
R: 5’- CCAATGGTGATGGGCTTG
F: 5’- GCCCAATCTCTATGGGAACA
R: 5’- CAGGGACCACACCAGCTC
F: 5’- AGAGTCCCCTTCCCCTGAG
R: 5’- GCTTCTACCAGGGACTGTCC
F: 5’- AGCCAGCCAACTTCTTGGA
R: 5’- GGATGGCTTCAACCTTAGGA
F: 5’- CAGCACAGGGAGGAATCAAT
R: 5’- CTGCTCCGTCATGTAGTGGA
F: 5’- TGAATGTTTTCAAGCCAATGAT
R: 5’- CCACCACGCAGTTTTCTGTA
F: 5’- CAGGACCAGCTGACAGCAC
R: 5’- AGCCTGCTCCGGCTTTAG
Cell cycle analysis
Cell cycle analysis was performed utilizing Muse™ Cell Analyzer (Merck Millipore) and following manufacturer’s instruction. Briefly, after the siRNAs transfection and subsequent cell cycle synchronization, the cells were washed with PBS and fixed in 70 % ice-cold ethanol. Cells were collected every two hours starting from 14 h after cell cycle releasing by addition of 10 % serum. After staining with Muse™ Cell Cycle Reagent, the cells were processed for cell cycle analysis.
Cell counting and viability
Cell counting and viability was determined by using the Muse® Count & Viability Assay Kit (Merck Millipore), according to the manufacturer’s instruction. Briefly, after the transfection with siRNAs, and subsequent cell cycle synchronization, the cells were collected and incubated with Muse™ Count &Viability Reagent. The number of viable cells were counted by using Muse™ Cell Analyzer (Merck Millipore).
Cell proliferation was determined by using the Cell Proliferation ELISA, BrdU (colorimetric) (Roche Diagnostics) Kit according to the manufacturer's instructions. Briefly, cells were seeded onto 96-well plate in an amount of 1000 cells/well. After siRNAs transfection and subsequent synchronization, cells were labeled with BrdU for 24 h. Then, cells were fixed, incubated with anti-BrdU antibodies and the BrdU incorporation was quantified by colorimetric reaction. Absorbance at 450 nm was measured by using an automated microplate reader (Wallac 1420 Multilabel Counter, Perkin Elmer).
This work was supported by National Science Center (Poland) (project grant no. 2011/02/A/NZ1/00009 to G.W.).
Source of support
National Science Center (Poland) (project grant no. 2011/02/A/NZ1/00009
- Barańska S, Glinkowska M, Herman-Antosiewicz A, Maciąg-Dorszyńska M, Nowicki D, Szalewska-Pałasz A, et al. Replicating DNA by cell factories: roles of central carbon metabolism and transcription in the control of DNA replication in microbes, and implications for understanding this process in human cells. Microb Cell Fact. 2013;12:55.View ArticlePubMed CentralPubMedGoogle Scholar
- Scholefield G, Veening JW, Murray H. DnaA and ORC: more than DNA replication initiators. Trends Cell Biol. 2011;21(3):188–94.View ArticlePubMedGoogle Scholar
- Węgrzyn A, Węgrzyn G. Inheritance of the replication complex: a unique or common phenomenon in the control of DNA replication? Arch Microbiol. 2001;175(2):86–93.View ArticlePubMedGoogle Scholar
- Janniere L, Canceill D, Suski C, Kanga S, Dalmais B, Lestini R, et al. Genetic evidence for a link between glycolysis and DNA replication. PLoS One. 2007;2(5), e447.View ArticlePubMed CentralPubMedGoogle Scholar
- Maciąg M, Nowicki D, Janniere L, Szalewska-Pałasz A, Węgrzyn G. Genetic response to metabolic fluctuations: correlation between central carbon metabolism and DNA replication in Escherichia coli. Microb Cell Fact. 2011;10:19.View ArticlePubMed CentralPubMedGoogle Scholar
- Maciąg-Dorszyńska M, Ignatowska M, Janniere L, Węgrzyn G, Szalewska-Pałasz A. Mutations in central carbon metabolism genes suppress defects in nucleoid position and cell division of replication mutants in Escherichia coli. Gene. 2012;503(1):31–5.View ArticlePubMedGoogle Scholar
- Konieczna A, Szczepańska A, Sawiuk K, Łyżeń R, Węgrzyn G. Enzymes of the central carbon metabolism: are they linkers between transcription, DNA replication, and carcinogenesis? Med Hypotheses. 2015;84(1):58–67.View ArticlePubMedGoogle Scholar
- Lincet H, Icard P. How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? Oncogene. 2014. doi:10.1038/onc.2014.320.PubMedGoogle Scholar
- Glinkowska M, Boss L, Węgrzyn G. DNA replication control in microbial cell factories. Heidelberg: Springer; 2015.View ArticleGoogle Scholar
- Hu JW, Sun P, Zhang DX, Xiong WJ, Mi J. Hexokinase 2 regulates G1/S checkpoint through CDK2 in cancer-associated fibroblasts. Cell Signal. 2014;26(10):2210–6.View ArticlePubMedGoogle Scholar
- Chen J, Zhang S, Li Y, Tang Z, Kong W. Hexokinase 2 overexpression promotes the proliferation and survival of laryngeal squamous cell carcinoma. Tumour Biol. 2014;35(4):3743–53.View ArticlePubMedGoogle Scholar
- Calvo MN, Bartronsa R, Castanoc E, Peralesb JC, Navarro-Sabatea A, Manzanoa A. PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett. 2006;580(13):3308–14.View ArticlePubMedGoogle Scholar
- Phadke MS, Krynetskaia NF, Mishra AK, Krynetskiy E. glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines. J Pharmacol Exp Ther. 2009;331(1):77–86.View ArticlePubMed CentralPubMedGoogle Scholar
- Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc romoter binding protein 1 (MBP-1). FEBS Lett. 2000;473(1):47–52.View ArticlePubMedGoogle Scholar
- Wang W, Wang L, Endoh A, Hummelke G, Hawks CL, Hornsby PJ. Identification of α-enolase as a nuclear DNA-binding protein in the zona fasciculata but not the zona reticularis of the human adrenal cortex. J Endocrinol. 2005;184(1):85–94.View ArticlePubMedGoogle Scholar
- Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, et al. Glycolysis module activated by hypoxia-inducible factor 1α is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol. 2008;33(4):725–31.PubMedGoogle Scholar
- Song Y, Luo Q, Long H, Hu Z, Que T, Zhang X, et al. Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma. Mol Cancer. 2014;13:65.View ArticlePubMed CentralPubMedGoogle Scholar
- Popanda O, Fox G, Thielmann HW. Modulation of DNA polymerases α, δ and ε by lactate dehydrogenase and 3-phosphoglycerate kinase. Biochim Biophys Acta. 1998;1397(1):102–17.View ArticlePubMedGoogle Scholar
- He H, Lee MC, Zheng LL, Zheng L, Luo Y. Integration of the metabolic/redox state, histone gene switching, DNA replication and S-phase progression by moonlighting metabolic enzymes. Biosci Rep. 2013;33(2), e00018.View ArticlePubMed CentralPubMedGoogle Scholar
- Augoff K, Hryniewicz-Jankowska A, Tabola R. Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer. Cancer Lett. 2015;358(1):1–7.View ArticlePubMedGoogle Scholar
- Sheng SL, Liu JJ, Dai YH, Sun XG, Xiong XP, Huang G, et al. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J. 2012;279(20):3898–910.View ArticlePubMedGoogle Scholar
- Rong Y, Wu W, Ni X, Kuang T, Jin D, Wang D, et al. Lactate dehydrogenase A is overexpressed in pancreatic cancer and promotes the growth of pancreatic cancer cells. Tumour Biol. 2013;34(3):1523–30.View ArticlePubMedGoogle Scholar
- Lin CC, Cheng TL, Tsai WH, Tsai HJ, Hu KH, Chang HC, et al. Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy. Sci Rep. 2012;2:785.PubMed CentralPubMedGoogle Scholar
- Guzy RD, Sharma B, Bell E, Chandel NS, Schumacker PT. Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol. 2008;28(2):718–31.View ArticlePubMed CentralPubMedGoogle Scholar
- Yogev O, Yogev O, Singer E, Shaulian E, Goldberg M, Fox TD, et al. Fumarase: A mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response. PLoS Biol. 2010;8(3), e1000328.View ArticlePubMed CentralPubMedGoogle Scholar
- Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev. 2012;26(12):1326–38.View ArticlePubMed CentralPubMedGoogle Scholar
- Zhang X, Lu F, Wang J, Yin F, Xu Z, Qi D, et al. Pluripotent stem cell protein Sox2 confers sensitivity to LSD1 inhibition in cancer cells. Cell Rep. 2013;5(2):445–57.View ArticlePubMedGoogle Scholar
- Krasnov GS, Dmitriev AA, Snezhkina AV, Kudryavtseva AV. Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target. Expert Opin Ther Targets. 2013;17(6):681–93.View ArticlePubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.